Kyrill S Rogacev1, Adam M Zawada2, Johanna Hundsdorfer2, Marina Achenbach3, Gerhard Held3, Danilo Fliser2, Gunnar H Heine2. 1. Department of Internal Medicine IV, Saarland University Medical Center, Homburg, Germany Department of Internal Medicine III, Saarland University Medical Center, Homburg, Germany. 2. Department of Internal Medicine IV, Saarland University Medical Center, Homburg, Germany. 3. Department of Internal Medicine I, Saarland University Medical Center, Homburg, Germany.
Abstract
BACKGROUND: Monocytes are critical in innate immunity and transplantation. Three monocyte subsets exist, CD14(++)CD16(-), CD14(++)CD16(+) and CD14(+)CD16(++) monocytes; cell counts of CD14(++)CD16(+) and CD14(+)CD16(++) monocytes are increased in pre-transplant chronic kidney disease. Interestingly, the effect of immunosuppressants on monocyte heterogeneity has not been well studied. METHODS: The impact of immunosuppressants on monocyte subsets was studied: (i) in 152 kidney transplant (KTx) recipients to characterize subset distribution in the steady state, (ii) in patients after autologous (n = 10) versus allogenic (n = 9) haematopoietic stem cell transplantation (HSCT) to analyse monocyte subset development and (iii) in an in vitro model to compare the effect of immunosuppressants on monocyte subset biology. RESULTS: In KTx, steroid intake was associated with higher total, CD14(++)CD16(-) and CD14(++)CD16(+) monocyte counts, but fewer CD14(+)CD16(++) monocytes, whereas intake of mycophenolate, calcineurin inhibitors (CNI) and mammalian target of rapamycin inhibitors (mTORI) did not affect monocyte (subset) counts. In linear regression analysis, only steroid intake was a significant determinant of monocyte (subset) counts: total monocytes (β = 0.331; P < 0.001), CD14(++)CD16(-) monocytes (β = 0.374; P < 0.001), CD14(++)CD16(+) monocytes (β = 0.221; P = 0.010) and CD14(+)CD16(++) monocytes (β = -0.169; P = 0.049). After HSCT, CD14(++)CD16(-) monocytes were the first to arise, followed by CD14(++)CD16(+) and later by CD14(+)CD16(++) monocytes. Monocyte subset distribution did not differ significantly in patients after allogenic compared with autologous transplantation. CNI, mycophenolate and methotrexate did not influence monocyte subset development, but modified surface receptor expression (CCR2, HLA-DR, ENG, TEK and TLR4) in allogenic HSCT. CONCLUSION: Chronic low-dose steroids are associated with monocytosis and higher counts of CD14(++)CD16(-) and of proinflammatory CD14(++)CD16(+) monocytes.
BACKGROUND: Monocytes are critical in innate immunity and transplantation. Three monocyte subsets exist, CD14(++)CD16(-), CD14(++)CD16(+) and CD14(+)CD16(++) monocytes; cell counts of CD14(++)CD16(+) and CD14(+)CD16(++) monocytes are increased in pre-transplant chronic kidney disease. Interestingly, the effect of immunosuppressants on monocyte heterogeneity has not been well studied. METHODS: The impact of immunosuppressants on monocyte subsets was studied: (i) in 152 kidney transplant (KTx) recipients to characterize subset distribution in the steady state, (ii) in patients after autologous (n = 10) versus allogenic (n = 9) haematopoietic stem cell transplantation (HSCT) to analyse monocyte subset development and (iii) in an in vitro model to compare the effect of immunosuppressants on monocyte subset biology. RESULTS: In KTx, steroid intake was associated with higher total, CD14(++)CD16(-) and CD14(++)CD16(+) monocyte counts, but fewer CD14(+)CD16(++) monocytes, whereas intake of mycophenolate, calcineurin inhibitors (CNI) and mammalian target of rapamycin inhibitors (mTORI) did not affect monocyte (subset) counts. In linear regression analysis, only steroid intake was a significant determinant of monocyte (subset) counts: total monocytes (β = 0.331; P < 0.001), CD14(++)CD16(-) monocytes (β = 0.374; P < 0.001), CD14(++)CD16(+) monocytes (β = 0.221; P = 0.010) and CD14(+)CD16(++) monocytes (β = -0.169; P = 0.049). After HSCT, CD14(++)CD16(-) monocytes were the first to arise, followed by CD14(++)CD16(+) and later by CD14(+)CD16(++) monocytes. Monocyte subset distribution did not differ significantly in patients after allogenic compared with autologous transplantation. CNI, mycophenolate and methotrexate did not influence monocyte subset development, but modified surface receptor expression (CCR2, HLA-DR, ENG, TEK and TLR4) in allogenic HSCT. CONCLUSION: Chronic low-dose steroids are associated with monocytosis and higher counts of CD14(++)CD16(-) and of proinflammatory CD14(++)CD16(+) monocytes.
Authors: Benjamin J Kopecky; Christian Frye; Yuriko Terada; Keki R Balsara; Daniel Kreisel; Kory J Lavine Journal: Am J Transplant Date: 2020-01-29 Impact factor: 8.086
Authors: Adam M Zawada; Jenny S Schneider; Anne I Michel; Kyrill S Rogacev; Björn Hummel; Nicolas Krezdorn; Soeren Müller; Björn Rotter; Peter Winter; Rima Obeid; Jürgen Geisel; Danilo Fliser; Gunnar H Heine Journal: Epigenetics Date: 2016-03-28 Impact factor: 4.528
Authors: V Švachová; L Krupičková; M Novotný; M Fialová; K Mezerová; E Čečrdlová; V Lánská; A Slavčev; O Viklický; O Viklický; I Stříž Journal: Physiol Res Date: 2021-09-10 Impact factor: 1.881
Authors: Yannick van Sleen; Qi Wang; Kornelis S M van der Geest; Johanna Westra; Wayel H Abdulahad; Peter Heeringa; Annemieke M H Boots; Elisabeth Brouwer Journal: Sci Rep Date: 2017-07-26 Impact factor: 4.379
Authors: Saskia Scholz; Faezzah Baharom; Gregory Rankin; Kimia T Maleki; Shawon Gupta; Sindhu Vangeti; Jamshid Pourazar; Andrea Discacciati; Jonas Höijer; Matteo Bottai; Niklas K Björkström; Johan Rasmuson; Magnus Evander; Anders Blomberg; Hans-Gustaf Ljunggren; Jonas Klingström; Clas Ahlm; Anna Smed-Sörensen Journal: PLoS Pathog Date: 2017-06-22 Impact factor: 6.823
Authors: Ana Isabel Sánchez-Fructuoso; Isabel Pérez-Flores; Rosalia Valero; Maria Angeles Moreno; Miguel Fernandez-Arquero; Elena Urcelay; Cristina Fernández-Pérez; Jose Luis Santiago Journal: J Immunol Res Date: 2016-09-29 Impact factor: 4.818
Authors: Xin Zhou; Xin-Lin Liu; Wen-Jie Ji; Jun-Xiang Liu; Zhao-Zeng Guo; Dong Ren; Yong-Qiang Ma; Shan Zeng; Zhong-Wei Xu; Hong-Xia Li; Peizhong Peter Wang; Zhuoli Zhang; Yu-Ming Li; Brandon C Benefield; Adam M Zawada; Edward B Thorp; Daniel C Lee; Gunnar H Heine Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889
Authors: B Thaler; P J Hohensinner; K A Krychtiuk; P Matzneller; L Koller; M Brekalo; G Maurer; K Huber; M Zeitlinger; B Jilma; J Wojta; W S Speidl Journal: Sci Rep Date: 2016-07-22 Impact factor: 4.379